Then, we investigated the potential association between the upregulation of HOXA9 expression and epigenetic variation by examining the promoter DNA methylation status across all 11 TCGA cancer types using the same GDC-TCGA datasets employed for gene expression analysis. This evidence concerns the gene HOXA9 and cancer.